| Analysis of expression and function of the inhibitory receptor ILT2 in lymphocytes from patients with autoimmune thyroid disease. | |
| | |
MedLine Citation:
|
PMID: 21551166 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Objective: Autoimmune thyroid disease (AITD) is characterized by different defects in immunoregulatory mechanisms. The immunoglobulin-like transcript receptor 2 (ILT2 or LIR1/CD85j) exerts an important immunoregulatory role. We hypothesized that the lymphocytes from AITD patients have a diminished expression and function of ILT2. The aim of this work was to study the expression and function of ILT2 in lymphocytes from patients with AITD. Design and methods: Eighteen patients with Hashimoto's thyroiditis (HT), twenty with Graves' disease (GD), and twenty-six healthy controls were studied. ILT2 expression was analyzed by flow cytometry and immunohistochemistry in peripheral blood mononuclear cells (PBMC), and thyroid tissue. The regulatory function of ILT2 was assessed by an assay of inhibition of lymphocyte proliferation, and by analysis of cell cycle progression. The effect of ILT2 on cytokine synthesis was also evaluated. Results: We found a significant increased expression of ILT2 by lymphocytes in AITD patients. ILT2 was also detected in the leukocyte infiltrate of thyroid tissue from HT patients. In contrast, a significant diminished inhibitory activity of ILT2 on cell proliferation was observed in AITD patients. In addition, PBMC from AITD patients showed a diminished synthesis of IL-10 upon ILT2 engagement. Conclusions: The abnormal expression and function of ILT2 detected in AITD suggests that this receptor may participate in the pathogenesis of this condition. |
| | |
Authors:
|
Lesly Doníz-Padilla; Amalia Paniagua; Pilar Sandoval-Correa; Adriana Monsiváis-Urenda; Susanna Leskela; Monica Marazuela; Roberto González-Amaro |
Related Documents
:
|
12812266 - Hyperhomocysteinemia and end-stage renal disease: determinants and association with car... 2959596 - Parasympathetic function in huntington's disease. 17470306 - Evaluation of plasma fibronectine level as a probable indicator for tympanosclerosis. 3557656 - Biofiltration, a new method of short hemodiafiltration: preliminary report. 7965516 - Congenital diaphragmatic hernia and associated anomalies: their incidence, identificati... 21139716 - Clinical profile of pulmonary aspergilloma complicating residual tubercular cavitations... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-5-6 |
Journal Detail:
|
Title: European journal of endocrinology / European Federation of Endocrine Societies Volume: - ISSN: 1479-683X ISO Abbreviation: - Publication Date: 2011 May |
Date Detail:
|
Created Date: 2011-5-9 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9423848 Medline TA: Eur J Endocrinol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
L Doníz-Padilla, Immunology, Facultad de Medicina, UASLP, SLP, Mexico. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Testicular size development and reproductive hormones in boys and adult males with Noonan syndrome: ...
Next Document: Gender-related differences in MEN1 lesion occurrence and diagnosis.A 734-case cohort study from the ...